Menomune
PATIENT INFORMATION
Patients, parents or guardians should be fully informed of the benefits and risks of immunization with Menomune (meningococcal polysaccharide vaccine) -A/C/Y/W-135 vaccine.
Patients, parents or guardians should be instructed to report any serious adverse reactions to their health-care provider.
As part of the patient's immunization record, the date, lot number and manufacturer of the vaccine administered should be recorded.22,23,24
REFERENCES
22. CDC. National Childhood Vaccine Injury Act: requirements for permanent vaccination records and for reporting of selected events after vaccination. MMWR 37: 197-200, 1988
23. Food and Drug Administration. New reporting requirements for vaccine adverse events. FDA Drug Bull 18 (2), 16-18, 1988
24. CDC. Vaccine Adverse Event Reporting System - United States. MMWR 39: 730-733, 1990
Last reviewed on RxList: 9/18/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Menomune Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
